These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome. Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403 [TBL] [Abstract][Full Text] [Related]
3. [Activity and distribution of plasma platelet-activating factor acetylhydrolase in polycystic ovary syndrome patients with insulin resistance]. Wan DH; Fan P; Bai H; Song Q; Liu HW Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):30-4. PubMed ID: 20367923 [TBL] [Abstract][Full Text] [Related]
4. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome. Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome. Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780 [TBL] [Abstract][Full Text] [Related]
6. Glucose metabolism in overweight Hispanic adolescents with and without polycystic ovary syndrome. Nur MM; Newman IM; Siqueira LM Pediatrics; 2009 Sep; 124(3):e496-502. PubMed ID: 19706563 [TBL] [Abstract][Full Text] [Related]
7. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome. Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036 [TBL] [Abstract][Full Text] [Related]
9. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
10. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061 [TBL] [Abstract][Full Text] [Related]
11. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
12. Ovarian SAHA syndrome is associated with a more insulin-resistant profile and represents an independent risk factor for glucose abnormalities in women with polycystic ovary syndrome: a prospective controlled study. Dalamaga M; Papadavid E; Basios G; Vaggopoulos V; Rigopoulos D; Kassanos D; Trakakis E J Am Acad Dermatol; 2013 Dec; 69(6):922-30. PubMed ID: 24120563 [TBL] [Abstract][Full Text] [Related]
13. Plasma adiponectin and insulin resistance in women with polycystic ovary syndrome. Ardawi MS; Rouzi AA Fertil Steril; 2005 Jun; 83(6):1708-16. PubMed ID: 15950640 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. DeUgarte CM; Bartolucci AA; Azziz R Fertil Steril; 2005 May; 83(5):1454-60. PubMed ID: 15866584 [TBL] [Abstract][Full Text] [Related]
15. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. Hutchison SK; Stepto NK; Harrison CL; Moran LJ; Strauss BJ; Teede HJ J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534 [TBL] [Abstract][Full Text] [Related]
16. Use of fasting blood to assess the prevalence of insulin resistance in women with polycystic ovary syndrome. Carmina E; Lobo RA Fertil Steril; 2004 Sep; 82(3):661-5. PubMed ID: 15374711 [TBL] [Abstract][Full Text] [Related]
17. Failure of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fulghesu AM; Angioni S; Portoghese E; Milano F; Batetta B; Paoletti AM; Melis GB Fertil Steril; 2006 Aug; 86(2):398-404. PubMed ID: 16769061 [TBL] [Abstract][Full Text] [Related]
18. [Comparison of HOMA IR with the minimal model for measuring insulin sensitivity in polycystic ovary syndrome]. Amador N; Espinoza G; Guízar JM; González M; Alpízar M Rev Invest Clin; 2001; 53(5):407-12. PubMed ID: 11795106 [TBL] [Abstract][Full Text] [Related]
19. Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome. Kulshreshtha B; Ganie MA; Praveen EP; Gupta N; Lal Khurana M; Seith A; Dwivedi SN; Kumar G; Ammini AC Gynecol Endocrinol; 2008 Nov; 24(11):637-43. PubMed ID: 19031221 [TBL] [Abstract][Full Text] [Related]
20. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome. Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]